CaMKII inhibition in type II pneumocytes decreases the inflammatory response to bleomycin. ELISA assays for TNF-α (A), IL-1β (B), and macrophage inflammatory protein-2 (MIP-2; C) in homogenates of lungs from WT or TG SPC AC3-I mice on days 3 and 14 after treatment with bleomycin or normal saline (cntrl) [n = 7 (WT cntrl), 4 (Tg SPC AC3-I cntrl), 13 (WT Bleo), and 8 (Tg SPC AC3-I Bleo)]. * P < 0.05.